Further studies show that MMP20/DSPP silencing in OSCC cells resulted in the downregulation of oral cancer stem cell markers and increased sensitivity of OSCC cells to cisplatin treatment. This evidence concerns the gene DSPP and lip and oral cavity carcinoma.